Joel Goldstein
17Patents
9h-index
18Co-inventors
69Inventor score
Filing activity: Jun 9, 1987 → Aug 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5837243A | Therapeutic compounds comprised of anti-Fc receptor antibodies | Chemistry; Metallurgy | 255 | Expired |
| US6270765A | Therapeutic compounds comprised of anti-Fc receptor antibodies | Chemistry; Metallurgy | 96 | Expired |
| US6365161B1 | Therapeutic compounds comprised of anti-FC receptor binding agents | Chemistry; Metallurgy | 60 | Expired |
| US6395272B1 | Therapeutic compounds comprised of anti-Fc receptor antibodies | Chemistry; Metallurgy | 59 | Expired |
| US6410690B1 | Therapeutic compounds comprised of anti-Fc receptor antibodies | Chemistry; Metallurgy | 39 | Expired |
| US6682928B2 | Cells expressing anti-Fc receptor binding components | Chemistry; Metallurgy | 31 | Expired |
| US4895716A | Stabilized formulations of gamma interferons | Human Necessities | 14 | Expired |
| US5714575A | Nucleic acids sequence, stress-induced proteins and uses thereof | Chemistry; Metallurgy | 13 | Expired |
| US5599808A | Aqueous indolocarbazole solutions | Human Necessities | 12 | Expired |
| US6333191A | Nucleic acids sequence, stress-induced proteins and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US10633444B2 | Agonistic antibodies that bind CD40 | Chemistry; Metallurgy | 4 | Active |
| US10941201B2 | Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies | Chemistry; Metallurgy | 2 | Active |
| US10865244B2 | Nucleic acids encoding agonistic antibodies that bind CD40 | Chemistry; Metallurgy | 1 | Active |
| US11332537B2 | Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs | Chemistry; Metallurgy | 1 | Active |
| US11459393B2 | Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs | Chemistry; Metallurgy | 0 | Active |
| US12297266B2 | Agonistic antibodies that bind human CD40 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7316812B2 | Cells expressing anti-Fc receptor binding components | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.